Pharma Focus Asia
KP - Sustainable Packaging Solutions

FUJIFILM Diosynth BiotechnologiesPlans for the Expansion in Denmark

Introduction:

FUJIFILM Diosynth Biotechnologies invests US$1.6 billion (11 billion Danish kroner)for the expansion in Hillerod, Denmark.

Features:

The expansion increases the capacity of the existing site by adding 8 x 20,000L bioreactors and two downstream processing streams.

The new site will adda total of 20 x 20,000L bioreactors for producing drug substance complemented by comprehensive drug product and finished goods services. Moreover, the addition of bioreactors will makeone of the largest CDMO site in Europe.

The expansion further strengthens cell culture manufacturing services.  The project also provides measures to support new “Green Value Climate Strategy” by targeting carbon-free energy by bringing net zero CO2 emissions by the end of Fiscal Year 2040. In addition, it also provideswater conservation and renewable energy, among other green pushes.

The new project is expected to be fully opeartional in summer 2026 and create over 450 new jobs.

Specifications:

NameFUJIFILM Diosynth Biotechnologies
TypeNew Construction
BudgetUSD 1.6 billion (11 billion Danish kroner)
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?